Press releases
SOMAÍ Joins Forces with Dascoli to Advance Swiss Medical Cannabis Market
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, is proud to announce its entry into Switzerland through a strategic partnership with Dascoli Pharma AG, a Switzerland-based pharmaceutical company specializing in the supply, distribution, and professional training of medical cannabis.
